LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 WZ-4-145
0.04
uM
LJP6
 0.8132 0.0299 0.7301 0.0399
BT-20 XMD16-144
0.04
uM
LJP5
 0.8832 0.0884 0.8339 0.1241
BT-20 Brivanib
0.04
uM
LJP5
 0.9715 0.0191 0.9598 0.0273
BT-20 Buparlisib
0.04
uM
LJP5
 1.0268 0.0128 1.0395 0.0192
BT-20 BX-912
0.04
uM
LJP5
 0.9281 0.0069 0.8962 0.0082
BT-20 Canertinib
0.04
uM
LJP6
 0.8981 0.0145 0.8517 0.0232
BT-20 Celastrol
0.04
uM
LJP6
 1.0419 0.0144 1.0599 0.0202
BT-20 CGP60474
0.04
uM
LJP5
 0.9008 0.0561 0.8566 0.0796
BT-20 CGP60474
0.04
uM
LJP6
 0.2034 0.0090 -0.1546 0.0285
BT-20 CHIR-99021
0.04
uM
LJP6
 0.9136 0.0488 0.8745 0.0700
BT-20 CP724714
0.04
uM
LJP5
 0.9558 0.0054 0.9360 0.0079
BT-20 CP466722
0.04
uM
LJP5
 1.0792 0.0067 1.1144 0.0076
BT-20 Crizotinib
0.04
uM
LJP5
 0.8539 0.0161 0.7877 0.0261
BT-20 Momelotinib
0.04
uM
LJP5
 0.9534 0.0359 0.9337 0.0515
BT-20 Dasatinib
0.04
uM
LJP5
 0.8742 0.0349 0.8179 0.0492
BT-20 Dasatinib
0.04
uM
LJP6
 0.5526 0.0929 0.3571 0.1238
BT-20 Dovitinib
0.04
uM
LJP5
 0.8753 0.0196 0.8186 0.0307
BT-20 Enzastaurin
0.04
uM
LJP5
 1.0329 0.0495 1.0453 0.0721
BT-20 Erlotinib
0.04
uM
LJP5
 0.8993 0.0149 0.8548 0.0196
BT-20 Foretinib
0.04
uM
LJP5
 1.0384 0.0248 1.0543 0.0351
BT-20 R406
0.04
uM
LJP6
 0.9686 0.0439 0.9540 0.0631
BT-20 Pictilisib
0.04
uM
LJP6
 0.7617 0.0213 0.6548 0.0306
BT-20 Gefitinib
0.04
uM
LJP6
 1.0119 0.0387 1.0189 0.0558
BT-20 Geldanamycin
0.04
uM
LJP5
 0.4607 0.0100 0.2182 0.0257
BT-20 Geldanamycin
0.04
uM
LJP6
 0.4608 0.0631 0.2217 0.0782